Chronic Low Grade Inflammation in Pathogenesis of PCOS
Open accessThe DOI matches its Crossref record; 97 of the 99 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a one of the most common endocrine disorders, with a prevalence rate of 5–10% in reproductive aged women. It’s characterized by (1) chronic anovulation, (2) biochemical and/or clinical hyperandrogenism, and (3) polycystic ovarian morphology. PCOS has significant clinical implications and can lead to health problems related to the accumulation of adipose tissue, such as obesity, insulin resistance, metabolic syndrome, and type 2 diabetes. There is also evidence that PCOS patients are at higher risk of cardiovascular diseases, atherosclerosis, and high blood pressure. Several studies have reported the association between polycystic ovary syndrome (PCOS) and low-grade chronic inflammation. According to known data, inflammatory markers or their gene markers are higher in PCOS patients. Correlations have been found between increased levels of C-reactive protein (CRP), interleukin 18 (IL-18), tumor necrosis factor (TNF-α), interleukin 6 (IL-6), white blood cell count (WBC), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) in the PCOS women compared with age- and BMI-matched controls. Women with PCOS present also elevated levels of AGEs and increased RAGE (receptor for advanced glycation end products) expression. This chronic inflammatory state is aggravating by obesity and hyperinsulinemia. There are studies describing mutual impact of hyperinsulinemia and obesity, hyperandrogenism, and inflammatory state. Endothelial cell dysfunction may be also triggered by inflammatory cytokines. Many factors involved in oxidative stress, inflammation, and thrombosis were proposed as cardiovascular risk markers showing the endothelial cell damage in PCOS. Those markers include asymmetric dimethylarginine (ADMA), C-reactive protein (CRP), homocysteine, plasminogen activator inhibitor-I (PAI-I), PAI-I activity, vascular endothelial growth factor (VEGF) etc. It was also proposed that the uterine hyperinflammatory state in polycystic ovary syndrome may be responsible for significant pregnancy complications ranging from miscarriage to placental insufficiency. In this review, we discuss the most importance evidence concerning the role of the process of chronic inflammation in pathogenesis of PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“COCs also exacerbate the inflammatory state present in these patients, which is likely related to increased aldosterone–renin ratio and CRP [12,14].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“The release of inflammatory markers is associated with long-term metabolic complications and high cardiovascular risk [12].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Macrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186 · cited 1×
“Obesity is a metabolic condition characterized by chronic inflammation state with higher pro-inflammatory cytokines, chemokines, and oxidative stress (OS) markers levels [5,6].”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161
Metabolic Inflammation and Insulin Resistance in Obesity
Wu, H., & Ballantyne, C. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315896 · Cited by 1,059
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Lumeng, C. N., DelProposto, J. B., Westcott, D. J., & Saltiel, A. R. (2008) · Diabetes · doi:10.2337/db08-0872 · Cited by 917
Obesity and the polycystic ovary syndrome
Gambineri, A., Pelusi, C., Vicennati, V, Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 836
Lee, B.-C., & Lee, J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.017 · Cited by 695
Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 671
Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M., & Escobar-Morreale, H. F. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms059 · Cited by 655
Low grade chronic inflammation in women with polycystic ovarian syndrome
Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7580 · Cited by 640
The macrophage switch in obesity development
Castoldi, A., Naffah de Souza, C., Câmara, N. O. S., & Moraes-Vieira, P. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00637 · Cited by 575
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
Escobar-Morreale, H. F., Luque-Ramírez, M., & González, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.11.036 · Cited by 517
Martin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516 · cited 1×
“Hyperleptinemia promotes production of proinflammatory cytokines, such as TNF, IL-6, and IL-12 [74].”
BackgroundEffects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., Roberts, K. A., & Nestler, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8207 · Cited by 492
Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170040 · Cited by 373
Boulman, N., Levy, Y., Leiba, R., Shachar, S., Linn, R., Zinder, O., & Blumenfeld, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031096 · Cited by 330
Is PCOS an inflammatory process?
Duleba, A. J., & Dokras, A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.023 · Cited by 327
Roles of oxidative stress in polycystic ovary syndrome and cancers
Zuo, T., Zhu, M., & Xu, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8589318 · Cited by 319
Diamanti-Kandarakis, E., Paterakis, T., Alexandraki, K., Piperi, C., Aessopos, A., Katsikis, I., Katsilambros, N., Kreatsas, G., & Panidis, D. (2006) · Human Reproduction · doi:10.1093/humrep/del003 · Cited by 258
Polycystic ovary syndrome and mitochondrial dysfunction
Zhang, J., Bao, Y., Zhou, X., & Zheng, L. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0509-4 · Cited by 258
Yu, H.-F., Chen, H.-S., Rao, D.-P., & Gong, J. (2016) · Medicine · doi:10.1097/md.0000000000004863 · Cited by 257
Orio, F., Palomba, S., Cascella, T., Di Biase, S., Manguso, F., Tauchmanovà, L., Nardo, L. G., Labella, D., Savastano, S., Russo, T., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0628 · Cited by 256
Tissue physiology and pathology of aromatase
Stocco, C. (2012) · Steroids · doi:10.1016/j.steroids.2011.10.013 · Cited by 246
Brown, D. W., Giles, W. H., & Croft, J. B. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00296-1 · Cited by 241
Generation and Characterization of Murine Alternatively Activated Macrophages
Weisser, S. B., McLarren, K. W., Kuroda, E., & Sly, L. M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-128-8_14 · Cited by 238
Local proliferation of macrophages in adipose tissue during obesity-induced inflammation
Haase, J., Weyer, U., Immig, K., Klöting, N., Blüher, M., Eilers, J., Bechmann, I., & Gericke, M. (2014) · Diabetologia · doi:10.1007/s00125-013-3139-y · Cited by 236
Low-Grade Inflammation, Obesity, and Diabetes
Pereira, S. S., & Alvarez-Leite, J. I. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0124-9 · Cited by 233
Modulation of the JNK Pathway in Liver Affects Insulin Resistance Status
Nakatani, Y., Kaneto, H., Kawamori, D., Hatazaki, M., Miyatsuka, T., Matsuoka, T.-A., Kajimoto, Y., Matsuhisa, M., Yamasaki, Y., & Hori, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406963200 · Cited by 232
Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S.-A., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T. G., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 228
Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & San Millán, J. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 198
Mani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K., & Howlett, T. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 194
Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity
Boulenouar, S., Michelet, X., Duquette, D., Alvarez, D., Hogan, A. E., Dold, C., O’Connor, D., Stutte, S., Tavakkoli, A., Winters, D., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.008 · Cited by 192
Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption
McClung, J. P., & Karl, J. P. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00145.x · Cited by 189
Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Piperi, C., Kalofoutis, A., & Creatsas, G. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02170.x · Cited by 178
Inflammatory Markers in Women with Polycystic Ovary Syndrome
Rudnicka, E., Kunicki, M., Suchta, K., Machura, P., Grymowicz, M., & Smolarczyk, R. (2020) · BioMed Research International · doi:10.1155/2020/4092470 · Cited by 176
Self-citationYang, P., Feng, J., Peng, Q., Liu, X., & Fan, Z. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9570616 · Cited by 167
Xiong, Y.-L., Liang, X.-Y., Yang, X., Li, Y., & Wei, L.-N. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.07.012 · Cited by 164
Advanced glycation end products and their relevance in female reproduction
Merhi, Z. O. (2013) · Human Reproduction · doi:10.1093/humrep/det383 · Cited by 153
Maiorino, M. I., Bellastella, G., Giugliano, D., & Esposito, K. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0872-6 · Cited by 152
Localization of androgen receptor expression in human bone marrow
Mantalaris, A., Panoskaltsis, N., Sakai, Y., Bourne, P. A., Chang, C., Messing, E. M., & Wu, J. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(0000)9999:9999<::aid-path803>3.0.co;2-w · Cited by 148
M1/M2 macrophage polarization in human obese adipose tissue
Chylíková, J., Dvořáčková, J., Tauber, Z., & Kamarád, V. (2018) · Biomedical Papers · doi:10.5507/bp.2018.015 · Cited by 148
The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome
van der Spuy, Z. M., & Dyer, S. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.06.001 · Cited by 138
Mediators of chronic inflammation in polycystic ovarian syndrome
Deligeoroglou, E., Vrachnis, N., Athanasopoulos, N., Iliodromiti, Z., Sifakis, S., Iliodromiti, S., Siristatidis, C. S., & Creatsas, G. C. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.683082 · Cited by 124
TNF- and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study
Escobar-Morreale, H. F., Calvo, R. M., Sancho, J., & Millán, J. L. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7770 · Cited by 121
Blüher, M., Bashan, N., Shai, I., Harman‐Boehm, I., Tarnovscki, T., Avinaoch, E., Stümvoll, M., Dietrich, A., Klöting, N., & Rudich, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0002 · Cited by 104
Inositols in polycystic ovary syndrome: An overview on the advances
Facchinetti, F., Unfer, V., Dewailly, D., Kamenov, Z. A., Diamanti-Kandarakis, E., Laganà, A. S., Nestler, J. E., & Soulage, C. O. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.002 · Cited by 102
Liu, M., Gao, J., Zhang, Y., Li, P., Wang, H., Ren, X., & Li, C. (2015) · Clinical Endocrinology · doi:10.1111/cen.12951 · Cited by 99
Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome
Shukla, P., & Mukherjee, S. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.02.006 · Cited by 96
Adipose Insulin Resistance in Normal-Weight Women With Polycystic Ovary Syndrome
Dumesic, D. A., Phan, J. D., Leung, K. L., Grogan, T. R., Ding, X., Li, X., Hoyos, L. R., Abbott, D. H., & Chazenbalk, G. D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02086 · Cited by 92
Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
Zeng, X., Zhang, Y., Tian, Q., Xue, Y., & An, R. (2016) · Medicine · doi:10.1097/md.0000000000004526 · Cited by 87
Kaya, C., Pabuçcu, R., Berker, B., & Şatıroğlu, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.070 · Cited by 81
MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndrome
Sathyapalan, T., & Atkin, S. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0755 · Cited by 81
Glintborg, D., Andersen, M., Richelsen, B., & Bruun, J. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03523.x · Cited by 78
Relationship between Advanced Glycation End Products and Steroidogenesis in PCOS
Garg, D., & Merhi, Z. O. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0205-6 · Cited by 75
Luo, L., Gu, F., Jie, H., Ding, C., Zhao, Q., Wang, Q., & Zhou, C. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.07.010 · Cited by 74
The Influence of Pentraxin 3 on the Ovarian Function and Its Impact on Fertility
Camaioni, A., Klinger, F. G., Campagnolo, L., & Salustri, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02808 · Cited by 72
de Jager, S. C. A., Kraaijeveld, A. O., Grauss, R. W., de Jager, W., Liem, S., van der Hoeven, B. L., Prakken, B. J., Putter, H., van Berkel, T. J. C., Atsma, D. E., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.06.003 · Cited by 70
Laganà, A. S., Rossetti, P., Sapia, F., Chiofalo, B., Buscema, M., Valenti, G., Rapisarda, A. M. C., & Vitale, S. G. (2017) · Intern J Endocrinol Metab · doi:10.5812/ijem.43695 · Cited by 66
Is the polycystic ovary syndrome associated with chronic inflammation per se?
Olszanecka‐Glinianowicz, M., Banaś, M., Zahorska‐Markiewicz, B., Janowska, J., Kocełak, P., Madej, P., & Klimek, K. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.037 · Cited by 61
González, F. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554918 · Cited by 60
González, F., Considine, R. V., Abdelhadi, O. A., & Acton, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa108 · Cited by 60
Hu, W., Qiao, J., Yan, Y., Wang, L., & Li, R. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.015 · Cited by 57
Kandaraki, E., Chatzigeorgiou, A., Piperi, C., Palioura, E., Palimeri, S., Korkolopoulou, P. A., Koutsilieris, M., & Papavassiliou, A. G. (2012) · Molecular Medicine · doi:10.2119/molmed.2012.00293 · Cited by 55
Milner, C. R. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.1.5 · Cited by 54
Çağlar, G. S., Öztaş, E., Karadağ, D., Pabuçcu, R., & Demırtaş, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.06.092 · Cited by 52
Polycystic ovary syndrome and the peripheral blood white cell count
Herlihy, A., Kelly, R. E., Hogan, J. L., O’Connor, N., Farah, N., & Turner, M. J. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.553693 · Cited by 52
Papalou, O., Livadas, S., Karachalios, A., Tolia, N., Kokkoris, P., Tripolitakis, K., & Diamanti‐Kandarakis, E. (2014) · HORMONES · doi:10.14310/horm.2002.1563 · Cited by 52
Phelan, N., O’Connor, A. S., Tun, T. K., Correia, N., Boran, G. P., Roche, H. M., & Gibney, J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04454.x · Cited by 50
Yun, J.-H., Choi, J.-W., Lee, K.-J., Shin, J.-S., & Baek, K. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-131 · Cited by 48
Kolbus, A., Walch, K., Nagele, F., Wenzl, R. J., Unfried, G., & Huber, J. C. (2006) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2006.08.002 · Cited by 46
Tola, E. N., Yalçın, S. E., & Dugan, N. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.05.014 · Cited by 44
Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome
Wang, Q., Luo, L., Lei, Q., Lin, M., Huang, X., Chen, M.-H., Zeng, Y., & Zhou, C. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.04.006 · Cited by 42
Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes
Aziz, M., Sidelmann, J. J., Faber, J. O., Wissing, M. L., Naver, K. V., Mikkelsen, A.-L., Nilas, L., & Skouby, S. O. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12706 · Cited by 41
The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome
Santos, A., Soares, N. P., Costa, E. C., de Sá, J. C. F., Azevedo, G. D., & Lemos, T. M. A. M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.976546 · Cited by 38
Tersigni, C., Vatish, M., D’Ippolito, S., Scambia, G., & Simone, N. D. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaz067 · Cited by 31
Circulating omentin-1 levels and inflammation in polycystic ovary syndrome
Franik, G., Sadłocha, M., Madej, P., Owczarek, A. J., Skrzypulec‐Plinta, V., Plinta, R., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2020) · Ginekologia Polska · doi:10.5603/gp.2020.0057 · Cited by 26
Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis
Meng, C. (2019) · Journal of International Medical Research · doi:10.1177/0300060519864493 · Cited by 25
Mitochondrial function in women with polycystic ovary syndrome
Cozzolino, M., & Seli, E. U. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000619 · Cited by 24
Elevated ovarian pentraxin 3 in polycystic ovary syndrome
Pan, J., Zhou, C., Zhou, Z., Yang, Z., Dai, T., Huang, H., & Li, J. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02105-4 · Cited by 23
Do adipose tissue macrophages promote insulin resistance or adipose tissue remodelling in humans?
Heilbronn, L. K., & Liu, B. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0036 · Cited by 22
Uysal, S., Işık, A. Z., Yalçın, S. E., Yigit, S. C., Yalçın, Y., & Özbay, P. Ö. (2015) · Obstetrics and Gynecology International · doi:10.1155/2015/278591 · Cited by 20
Mažibrada, I., Djukic, T. I., Perović, S., Pljesa-Ercegovac, M. S., Plavšić, L., Bojanin, D., Bjekić-Macut, J., Simić, P. D., Simic, T. P., Savic-Radojevic, A. R., et al. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0511 · Cited by 19
Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?
Şahin, F. K., Şahin, S. B., Balık, G., Ural, Ü. M., Tekın, Y. B., Cüre, M. C., Şentürk, Ş., Yuce, S., & Cüre, E. (2014) · PubMed · Cited by 18
Androgen Therapy for Acute Myeloid and Hairy Cell Leukemia
Wiernik, P. H. (2018) · Current Treatment Options in Oncology · doi:10.1007/s11864-018-0519-z · Cited by 14
Wyskida, K., Franik, G., Choręza, P. S., Pohl, N., Markuszewski, L., Owczarek, A. J., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1380176 · Cited by 13
Is Pentraxin 3 a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome?
Sarı, U., Kaygusuz, İ., & Kafalı, H. C. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000363744 · Cited by 11
Adipose Tissue Inflammation and Metabolic Disorders
Henriques, F. D. S., Bedard, A. H., & Júnior, M. L. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88631 · Cited by 11
Nejabati, H. R., Samadi, N., Roshangar, L., & Nouri, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116843 · Cited by 11
Wang, B., Zhou, S., Wang, J., Liu, J., Ni, F., Liu, C., Yan, J., Mu, Y., Cao, Y., & Ma, X. (2009) · Endocrine · doi:10.1007/s12020-009-9152-8 · Cited by 9
Wyskida, K., Franik, G., Pohl, N., Markuszewski, L., Owczarek, A. J., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1637535 · Cited by 9
Research works printed but not linked: 1
- Burhans, 2018, Contribution of AT inflammation to the development of T2D mellitus, Compr. Physiol., 9, 1
Cited by
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107282 · Cited by 253
Yang, J., & Chen, C. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0342 · Cited by 169
Fiorentino, G., Cimadomo, D., Innocenti, F., Soscia, D., Vaiarelli, A., Ubaldi, F. M., Gennarelli, G., Garagna, S., Rienzi, L., & Zuccotti, M. (2023) · Human Reproduction Update · doi:10.1093/humupd/dmac031 · Cited by 176
Metadata
- Authors
- Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B.
- Affiliations
- Medical University of Warsaw (PL)
- Warsaw University of Life Sciences (PL)
- Department of Gynaecological Endocrinology, Poznan University of Medical Sciences, 60-535 Poznan, Poland
- Corresponding author
- Rudnicka, Ewa
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-06
- Volume
- 22
- Issue
- 7
- Pages
- 3789
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8038770
- OpenAlex
- W3145310045
- Cited by
- 680
- References
- 99
- Citations by year
- 2026: 152 · 2025: 172 · 2024: 165 · 2023: 112 · 2022: 74 · 2021: 5
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, low-grade inflammation, inflammatory cytokines, C-reactive protein, advanced glycation end products, RAGE, hyperinsulinemia, obesity, endothelial dysfunction, oxidative stress, cardiovascular risk, pregnancy complications, hyperandrogenism, insulin resistance
- MeSH terms
- Aging, C-Reactive Protein, Chronic Disease, Diabetes Mellitus, Type 2, Female, Humans, Inflammation, Obesity, Polycystic Ovary Syndrome, Cytokines, Metabolic Syndrome, Endothelial Cells, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.